Concord Wealth Partners’s Ligand Pharmaceuticals LGND Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-12
| Closed | -$1.29K | – | 893 |
|
|
2024
Q4 | $1.29K | Hold |
12
| – | – | ﹤0.01% | 760 |
|
|
2024
Q3 | $1.2K | Buy |
+12
| New | +$1.2K | ﹤0.01% | 802 |
|
|
2022
Q3 | – | Sell |
-6
| Closed | – | – | 696 |
|
|
2022
Q2 | $0 | Sell |
6
-247
| -98% | – | ﹤0.01% | 1315 |
|
|
2022
Q1 | $18K | Hold |
253
| – | – | ﹤0.01% | 653 |
|
|
2021
Q4 | $24K | Buy |
253
+93
| +58% | +$8.82K | 0.01% | 603 |
|
|
2021
Q3 | $14K | Buy |
160
+57
| +55% | +$4.99K | 0.01% | 426 |
|
|
2021
Q2 | $8K | Buy |
+103
| New | +$8K | ﹤0.01% | 665 |
|